Riskpilot← Back to searchSign inGet full accessBiovac Danmark A/S
A/SDissolvedCVR 38880438Kringelholm 86Construction of utility projects for fluids · NACE 4221Est. 20171 employees
Revenue 2023
DKK -94K
+214% vs 2022
EBITDA margin
100.0%
-214% vs 2022
Equity ratio
-1421.6%
Financial strength
Net profit 2023
DKK -86K
-241% vs 2022
| Revenue | DKK -94K | +214% |
| EBITDA | DKK -94K | -214% |
| Net profit | DKK -86K | -241% |
| Total assets | DKK 113K | -45% |
| Equity | DKK -1,6M | -6% |
| Employees | 1 | — |
Legal name
Biovac Danmark A/S
CVR number
38880438
Legal form
Aktieselskab
NACE code
4221 · Construction of utility projects for fluids
Founded
24. august 2017
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af 2 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Address
Kringelholm 86
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | -263 | -52 | -30 | -30 | -94 |
| Staff expenses | -1 | -0 | -0 | -0 | -0 |
| EBITDA | -264 | -52 | -30 | -30 | -94 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -264 | -52 | -30 | -30 | -94 |
| Net financials | -21 | 12 | -37 | 5 | 8 |
| Profit before tax | -285 | -40 | -67 | -25 | -86 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -285 | -40 | -67 | -25 | -86 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 350 | 278 | 249 | 208 | 113 |
| Equity | -1.396 | -1.435 | -1.502 | -1.527 | -1.613 |
| Long-term debt | 1.251 | 1.264 | 1.276 | 1.289 | 1.302 |
| Short-term debt | 494 | 450 | 475 | 446 | 425 |
| Total debt | 1.745 | 1.713 | 1.751 | 1.735 | 1.727 |
EBITDA margin
-9379400.0%
This company
15.8%
Market median
-59363391% vs market
20192023
Equity ratio
-1421.6%
This company
38.2%
Market median
-3821% vs market
20192023
Return on equity
-8584400.0%
This company
18.4%
Market median
-46654448% vs market
20192023
Net profit margin
-8584400.0%
This company
8.1%
Market median
-105980347% vs market
20192023
Asset turnover
-0.83×
This company
1.12×
Market median
-174% vs market
20192023
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20192023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
PM Management | Management | 2019 – 2024 |
BE | Founder | 2017 – 2025 |
EM Management | Management | 2024 – 2025 |
PD Management | Management | 2017 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Board of Directors | 2021 – 2025 | |
| Board of Directors | 2017 – 2021 | |
| Board of Directors | 2021 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 15–19.99% | 15–19.99% | 2017 | |
| Individual | 100% | 100% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biovac Danmark A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Petter Mellquist | Management | 0 companies |
| Biovac Environmental Technology AS | Founder | 0 companies |
| Eskil Møllegaard | Management | 0 companies |
| Peter Dalgaard | Management | 0 companies |
| Hilde Mariann Hakø-Hauger | Board of Directors | 0 companies |
| Terje Wilhelmsen | Board of Directors | 0 companies |
| Anett Ingier Ottesen | Board of Directors | 0 companies |